Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacokinetics of Butyrate Tablet BKR-017
Sponsor: BioKier Inc.
Summary
The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.
Official title: A Phase 1 Study of Safety and Pharmacokinetics of BKR-017 in Individuals on Statin Therapy
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
9
Start Date
2025-07-16
Completion Date
2026-06-04
Last Updated
2026-06-09
Healthy Volunteers
Not specified
Conditions
Interventions
BKR-017
BKR-017 is an oral tablet formulation designed to target delivery of sodium butyrate to the colon via colon-targeting technology.
Locations (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States